CLINICAL  	CLINICAL  	 JJ	B-NP
BACKGROUND  	BACKGROUND  	 NNP	I-NP
ANALYSIS  	ANALYSIS  	 NNP	I-NP
ABOUT  	ABOUT  	 NNP	O
TRANSURETHRAL  	TRANSURETHRAL  	 NNP	B-NP
ELECTROCOAGULATION  	ELECTROCOAGULATION  	 NNP	I-NP
Transurethral  	Transurethral  	 NNP	I-NP
electrocoagulation  	electrocoagulation  	 NNS	I-NP
( 	( 	 -LRB-	O
TUC 	TUC 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
rare  	rare  	 JJ	O
event  	event  	 NN	O
but  	but  	 CC	O
occurs  	occurs  	 VBZ	O
in  	in  	 IN	O
a  	a  	 DT	O
constant  	constant  	 JJ	O
manner  	manner  	 NN	O
with  	with  	 IN	O
various  	various  	 JJ	O
causes  	causes  	 NNS	O
or  	or  	 CC	O
disorders  	disorders  	 NNS	O
and  	and  	 CC	O
reduces  	reduces  	 VBZ	O
patient  	patient  	 JJ	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life 	life 	 NN	O
.  	.  	 .	O
So  	So  	 RB	O
far  	far  	 RB	O
there  	there  	 EX	O
have  	have  	 VBP	O
been  	been  	 VBN	O
no  	no  	 DT	O
reports  	reports  	 NNS	O
focusing  	focusing  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
details  	details  	 NNS	O
of  	of  	 IN	O
TUC 	TUC 	 NNP	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
focused  	focused  	 VBD	O
on  	on  	 IN	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
background  	background  	 NN	I-NP
and  	and  	 CC	O
related  	related  	 JJ	O
causes  	causes  	 NNS	O
in  	in  	 IN	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
TUC  	TUC  	 NNP	B-NP
in  	in  	 IN	O
our  	our  	 PRP$	O
institution 	institution 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
identified  	identified  	 VBD	O
76  	76  	 CD	O
cases  	cases  	 NNS	O
( 	( 	 -LRB-	O
65  	65  	 CD	O
patients 	patients 	 NNS	O
)  	)  	 -RRB-	O
who  	who  	 WP	O
underwent  	underwent  	 VBD	O
TUC  	TUC  	 NNP	B-NP
at  	at  	 IN	O
Keio  	Keio  	 NNP	O
University  	University  	 NNP	O
Hospital  	Hospital  	 NNP	O
between  	between  	 IN	O
April  	April  	 NNP	O
2001  	2001  	 CD	O
and  	and  	 CC	O
March  	March  	 NNP	O
2011 	2011 	 CD	O
.  	.  	 .	O
We  	We  	 PRP	O
focused  	focused  	 VBD	O
on  	on  	 IN	O
patient  	patient  	 JJ	O
background 	background 	 NN	O
,  	,  	 ,	O
especially  	especially  	 RB	O
with  	with  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
primary  	primary  	 JJ	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
treatment  	treatment  	 NN	B-NP
modality 	modality 	 NN	I-NP
,  	,  	 ,	O
use  	use  	 NN	O
of  	of  	 IN	O
antiplatelet  	antiplatelet  	 NN	B-NP
or  	or  	 CC	O
anticoagulant  	anticoagulant  	 JJ	B-NP
agent 	agent 	 NN	I-NP
,  	,  	 ,	O
timing  	timing  	 NN	O
of  	of  	 IN	O
TUC 	TUC 	 NNP	B-NP
,  	,  	 ,	O
type  	type  	 NN	O
of  	of  	 IN	O
electrosurgical  	electrosurgical  	 JJ	B-NP
device 	device 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
transfusion 	transfusion 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
primary  	primary  	 JJ	B-NP
disease  	disease  	 NN	I-NP
for  	for  	 IN	I-NP
TUC  	TUC  	 NNP	I-NP
included  	included  	 VBD	I-NP
bladder  	bladder  	 JJ	I-NP
tumor  	tumor  	 NN	I-NP
( 	( 	 -LRB-	O
BT 	BT 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
31  	31  	 CD	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
benign  	benign  	 FW	B-NP
prostate  	prostate  	 FW	I-NP
hyperplasia  	hyperplasia  	 FW	I-NP
( 	( 	 -LRB-	O
BPH 	BPH 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
13 	13 	 CD	O
,  	,  	 ,	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
( 	( 	 -LRB-	O
PCa 	PCa 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
13 	13 	 CD	O
,  	,  	 ,	O
idiopathic  	idiopathic  	 JJ	B-NP
bladder  	bladder  	 NN	I-NP
bleeding  	bleeding  	 NN	I-NP
in  	in  	 IN	O
4 	4 	 CD	O
,  	,  	 ,	O
periarteritis  	periarteritis  	 JJ	B-NP
nodosa  	nodosa  	 NN	I-NP
in  	in  	 IN	O
3 	3 	 CD	O
,  	,  	 ,	O
uterine  	uterine  	 JJ	B-NP
cervical  	cervical  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
in  	in  	 IN	O
3 	3 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
others  	others  	 NNS	O
in  	in  	 IN	O
9 	9 	 CD	O
.  	.  	 .	O
TUC  	TUC  	 NNP	B-NP
after  	after  	 IN	O
transurethral  	transurethral  	 JJ	B-NP
resection  	resection  	 NNS	I-NP
( 	( 	 -LRB-	O
TUR 	TUR 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
38  	38  	 CD	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
including  	including  	 VBG	O
transurethral  	transurethral  	 JJ	B-NP
resection  	resection  	 NN	I-NP
of  	of  	 IN	I-NP
bladder  	bladder  	 JJ	I-NP
tumor  	tumor  	 NN	I-NP
( 	( 	 -LRB-	O
TURBT 	TURBT 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
26  	26  	 CD	O
of  	of  	 IN	O
31  	31  	 CD	O
BT  	BT  	 NNP	B-NP
cases  	cases  	 NNS	I-NP
and  	and  	 CC	O
transurethral  	transurethral  	 JJ	B-NP
resection  	resection  	 NN	I-NP
of  	of  	 IN	I-NP
prostate  	prostate  	 NNS	I-NP
( 	( 	 -LRB-	O
TURP 	TURP 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
12  	12  	 CD	O
of  	of  	 IN	O
13  	13  	 CD	O
BPH  	BPH  	 NN	B-NP
cases 	cases 	 NNS	I-NP
.  	.  	 .	O
After  	After  	 IN	O
TURBT 	TURBT 	 NNP	B-NP
,  	,  	 ,	O
TUC  	TUC  	 NNP	B-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
before  	before  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
urethral  	urethral  	 JJ	B-NP
catheter  	catheter  	 NN	I-NP
in  	in  	 IN	O
7  	7  	 CD	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
after  	after  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
urethral  	urethral  	 JJ	B-NP
catheter  	catheter  	 NN	I-NP
in  	in  	 IN	O
19  	19  	 CD	O
cases 	cases 	 NNS	O
.  	.  	 .	O
With  	With  	 IN	O
regard  	regard  	 NN	O
to  	to  	 TO	O
TUC  	TUC  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
TURP 	TURP 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
average  	average  	 NN	O
estimated  	estimated  	 VBD	B-NP
prostate  	prostate  	 JJ	I-NP
volume  	volume  	 NN	I-NP
in  	in  	 IN	O
TUC  	TUC  	 NNP	B-NP
cases  	cases  	 NNS	I-NP
before  	before  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
urethral  	urethral  	 JJ	B-NP
catheter  	catheter  	 NN	I-NP
was  	was  	 VBD	O
66.2  	66.2  	 CD	O
ml 	ml 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
larger  	larger  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
in  	in  	 IN	O
TUC  	TUC  	 NNP	B-NP
cases  	cases  	 NNS	I-NP
after  	after  	 IN	O
removal  	removal  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
urethral  	urethral  	 JJ	B-NP
catheter  	catheter  	 NN	I-NP
( 	( 	 -LRB-	O
46.1  	46.1  	 CD	O
ml 	ml 	 NN	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
0.045 	0.045 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
TUC  	TUC  	 NNP	B-NP
after  	after  	 IN	O
the  	the  	 DT	O
radiation  	radiation  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
was  	was  	 VBD	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
21  	21  	 CD	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
average  	average  	 JJ	O
time  	time  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
radiation  	radiation  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
to  	to  	 TO	O
TUC  	TUC  	 NNP	B-NP
was  	was  	 VBD	O
3.4  	3.4  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
7  	7  	 CD	O
months-10  	months-10  	 CD	B-NP
years 	years 	 NNS	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
TUC  	TUC  	 NNP	B-NP
was  	was  	 VBD	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
multiple  	multiple  	 JJ	O
causes  	causes  	 NNS	O
or  	or  	 CC	O
disorders 	disorders 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
75 	75 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
our  	our  	 PRP$	O
TUC  	TUC  	 NNP	B-NP
was  	was  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
BT 	BT 	 NNP	B-NP
,  	,  	 ,	O
BPH  	BPH  	 NNP	B-NP
or  	or  	 CC	O
PCa 	PCa 	 JJ	O
.  	.  	 .	O
TUC  	TUC  	 NNP	B-NP
associated  	associated  	 VBN	O
with  	with  	 IN	O
TURBT  	TURBT  	 NNP	B-NP
frequently  	frequently  	 RB	O
occurred  	occurred  	 VBN	O
within  	within  	 IN	O
1  	1  	 CD	O
week  	week  	 NN	B-NP
after  	after  	 IN	O
TURBT  	TURBT  	 NNP	B-NP
but  	but  	 CC	O
was  	was  	 VBD	O
still  	still  	 RB	O
observed  	observed  	 VBN	O
after  	after  	 IN	O
1  	1  	 CD	O
month  	month  	 NN	O
following  	following  	 VBG	O
the  	the  	 DT	O
operation 	operation 	 NN	O
.  	.  	 .	O
All  	All  	 DT	O
TUC  	TUC  	 NN	B-NP
associated  	associated  	 VBN	O
with  	with  	 IN	O
TURP  	TURP  	 NNP	B-NP
occurred  	occurred  	 VBD	O
within  	within  	 IN	O
3  	3  	 CD	O
weeks  	weeks  	 NNS	O
after  	after  	 IN	O
operation 	operation 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
average  	average  	 JJ	O
period  	period  	 NN	O
from  	from  	 IN	O
radiation  	radiation  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
to  	to  	 TO	O
TUC  	TUC  	 NNP	B-NP
was  	was  	 VBD	O
3.4  	3.4  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
7  	7  	 CD	O
months-10  	months-10  	 CD	B-NP
years 	years 	 NNS	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
TUC  	TUC  	 NNP	B-NP
associated  	associated  	 VBN	O
with  	with  	 IN	O
radiation  	radiation  	 NN	B-NP
cystitis  	cystitis  	 NNS	I-NP
could  	could  	 MD	O
occur  	occur  	 VB	O
beyond  	beyond  	 IN	O
5  	5  	 CD	O
years  	years  	 NNS	O
after  	after  	 IN	O
radiation 	radiation 	 NN	B-NP
.  	.  	 .	O
